And even that would give them a measure of the benefits. If it’s the same benefit that actual ADHD receives then it’s still a useful metric. If it’s less than the benefit when used for actual cases then, in aggregate, the benefits would be a low bar. Arguably that’s a better bias as it would make the benefits/costs decision more conservative. They’re taking the difference in measurements for each individual.